23andMe Genetic Data Bids

Order byBest matchMost fresh

Regeneron Pharmaceuticals to buy 23andMe and its data

23andMe (and Your Genetic Data) Sold to Regeneron in Bankruptcy Auction

The company and nearly all of its assets, including its biobank of customer genetic samples, have been purchased by American biotechnology company Regeneron Pharmaceuticals for a cool $256 million, t...

· 17h

· 19h

Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal

· 17h · on MSN

Now we know who's getting 23andMe's DNA data. Meet Regeneron Pharmaceuticals.

Regeneron agrees to buy bankrupt 23andMe

Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of customers' DNA da...

· 21h

· 23h

Struggling DNA testing firm 23andMe to be bought for $256m

· 1d

Bankrupt DNA testing company 23andMe to be bought by Regeneron

Genetic data will be safeguarded with 23andMe sale, drugmaker vows

Regeneron Pharmaceuticals said Monday it will acquire 23andMe’s DNA testing business and most of its assets out of bankruptcy and pledged to continue offering the popular consumer service and adopt it...

· 17h

· 1d

23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private

· 1d

Biotechnology company Regeneron buying 23andMe for $256 million

17h

23andMe to Be Bought by Biotech Company for $256 Million

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.

Fierce Biotech1d

Regeneron’s $256M bid wins 23andMe bankruptcy auction

The company has signed up to pay $256 million for 23andMe and nearly all of its assets, including its R&D services operations as well as its biobank of collected samples. The deal, which is subject to court approval, does not cover 23andMe’s Lemonaid Health telemedicine and virtual pharmacy business.

17 US dollars per gene data record: US pharmaceutical company takes over 23andme

The insolvent genetic analysis company 23andme is taken over by a pharmaceutical company that wants to continue the business and has promised data protection.

21hon MSN

23andMe bought by Regeneron in court auction

How exactly 23andMe will shake out after the Regeneron purchase is to be seen. The company has taken a dramatic fall in recent years, since going public. Hackers accessed the information of 6.9 million people in 2023 and 23andMe laid off over 200 people last year.